Efforts to generate a broadly protective vaccine for HIV/AIDS have been thwarted by the inability to create immunogens that elicit neutralizing antibodies to conserved sites in the envelope glycoprotein (Env). The gene discussed is ERVW-1; the disease is AIDS.